ZA957280B - Crystalline form of dihydro-2,3-benzodiazepine derivative - Google Patents
Crystalline form of dihydro-2,3-benzodiazepine derivativeInfo
- Publication number
- ZA957280B ZA957280B ZA957280A ZA957280A ZA957280B ZA 957280 B ZA957280 B ZA 957280B ZA 957280 A ZA957280 A ZA 957280A ZA 957280 A ZA957280 A ZA 957280A ZA 957280 B ZA957280 B ZA 957280B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydro
- crystalline form
- benzodiazepine derivative
- benzodiazepine
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29864594A | 1994-08-31 | 1994-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA957280B true ZA957280B (en) | 1997-02-28 |
Family
ID=23151416
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA957278A ZA957278B (en) | 1994-08-31 | 1995-08-30 | Stereoselective process for producing dihydro-2,3-benzo-diazepine derivatives |
ZA957279A ZA957279B (en) | 1994-08-31 | 1995-08-30 | Physical form of dihydro-2,3-benzodiazepine derivative |
ZA957280A ZA957280B (en) | 1994-08-31 | 1995-08-30 | Crystalline form of dihydro-2,3-benzodiazepine derivative |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA957278A ZA957278B (en) | 1994-08-31 | 1995-08-30 | Stereoselective process for producing dihydro-2,3-benzo-diazepine derivatives |
ZA957279A ZA957279B (en) | 1994-08-31 | 1995-08-30 | Physical form of dihydro-2,3-benzodiazepine derivative |
Country Status (13)
Country | Link |
---|---|
US (3) | US5665878A (xx) |
KR (2) | KR100386933B1 (xx) |
CO (3) | CO4410199A1 (xx) |
HU (1) | HU223846B1 (xx) |
MY (2) | MY117754A (xx) |
NZ (1) | NZ272896A (xx) |
PE (3) | PE28196A1 (xx) |
RU (1) | RU2142465C1 (xx) |
SI (2) | SI0699678T1 (xx) |
TW (3) | TW393485B (xx) |
UA (3) | UA41354C2 (xx) |
YU (3) | YU49288B (xx) |
ZA (3) | ZA957278B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747492A (en) * | 1992-07-24 | 1998-05-05 | The Regents Of The University Of California | Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by ampa receptors |
KR100478129B1 (ko) * | 1996-12-20 | 2005-12-26 | 주식회사 효성 | 투습방수직물의제조방법 |
CA2453182A1 (en) * | 2001-07-10 | 2003-01-23 | Meredith L. Greene | Crystalline thiazine oxazolidinones |
JP4159988B2 (ja) | 2001-08-15 | 2008-10-01 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | N−[2−(ジエチルアミノ)エチル]−5−[(5−フルオロ−1,2−ジヒドロ−2−オキソ−3h−インドール−3−イリデン)メチル]−2,4−ジメチル−1h−ピロール−3−カルボキシアミドのリンゴ酸塩を含む結晶、その製法およびその組成物 |
KR20040032188A (ko) * | 2002-10-01 | 2004-04-17 | 기아자동차주식회사 | 개량형 아웃사이드 미러 |
EP1979308A1 (en) * | 2005-12-30 | 2008-10-15 | EGIS Gyógyszergyár Nyrt | Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
US20160137573A1 (en) * | 2014-11-14 | 2016-05-19 | Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, | Methods and catalyst systems for carbon dioxide conversion |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3794642A (en) * | 1973-01-15 | 1974-02-26 | Lilly Co Eli | Oxidation of substituted methanes to the corresponding substituted methanols |
US4560510A (en) * | 1984-04-06 | 1985-12-24 | A. H. Robins Company, Incorporated | Process and intermediates for the preparation of aryl substituted pyrido[1,4]benzodiazepines |
HU191698B (en) * | 1984-07-27 | 1987-03-30 | Gyogyszerkutato Intezet | Process for producing new 1-aryl-5h-2beta-benzodiazepines |
HU198494B (en) * | 1986-08-15 | 1989-10-30 | Gyogyszerkutato Intezet | Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same |
EP0357787B1 (en) * | 1988-02-12 | 1996-05-08 | Daicel Chemical Industries, Ltd. | Process for preparing optically active 2-hydroxy acid derivatives |
HU219778B (hu) | 1990-12-21 | 2001-07-30 | Gyógyszerkutató Intézet Közös Vállalat | Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények |
HU206719B (en) * | 1990-12-21 | 1992-12-28 | Gyogyszerkutato Intezet | Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them |
HU219777B (hu) | 1993-07-02 | 2001-07-30 | Gyógyszerkutató Intézet Kft. | Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására |
-
1995
- 1995-03-28 US US08/413,036 patent/US5665878A/en not_active Expired - Lifetime
- 1995-03-28 US US08/412,242 patent/US6329364B1/en not_active Expired - Fee Related
- 1995-03-28 US US08/413,024 patent/US6288057B1/en not_active Expired - Fee Related
- 1995-07-12 CO CO95030588A patent/CO4410199A1/es unknown
- 1995-07-12 PE PE1995273616A patent/PE28196A1/es not_active Application Discontinuation
- 1995-07-12 TW TW084107231A patent/TW393485B/zh not_active IP Right Cessation
- 1995-07-12 PE PE1995273614A patent/PE32996A1/es not_active Application Discontinuation
- 1995-07-12 CO CO95030585A patent/CO4410198A1/es unknown
- 1995-07-12 PE PE1995273615A patent/PE32896A1/es not_active Application Discontinuation
- 1995-07-12 CO CO95030584A patent/CO4410197A1/es unknown
- 1995-07-12 TW TW084107230A patent/TW390881B/zh not_active IP Right Cessation
- 1995-07-12 TW TW084107229A patent/TW372965B/zh not_active IP Right Cessation
- 1995-08-29 MY MYPI95002564A patent/MY117754A/en unknown
- 1995-08-30 KR KR1019950027527A patent/KR100386933B1/ko not_active IP Right Cessation
- 1995-08-30 ZA ZA957278A patent/ZA957278B/xx unknown
- 1995-08-30 MY MYPI95002583A patent/MY118394A/en unknown
- 1995-08-30 ZA ZA957279A patent/ZA957279B/xx unknown
- 1995-08-30 NZ NZ272896A patent/NZ272896A/en not_active IP Right Cessation
- 1995-08-30 HU HU0003319A patent/HU223846B1/hu not_active IP Right Cessation
- 1995-08-30 YU YU57695A patent/YU49288B/sh unknown
- 1995-08-30 SI SI9530701T patent/SI0699678T1/xx unknown
- 1995-08-30 KR KR1019950027528A patent/KR100386934B1/ko not_active IP Right Cessation
- 1995-08-30 YU YU57795A patent/YU49289B/sh unknown
- 1995-08-30 ZA ZA957280A patent/ZA957280B/xx unknown
- 1995-08-30 UA UA95083976A patent/UA41354C2/uk unknown
- 1995-08-30 UA UA95083977A patent/UA44698C2/uk unknown
- 1995-08-30 RU RU95114550A patent/RU2142465C1/ru not_active IP Right Cessation
- 1995-08-30 UA UA95083975A patent/UA45309C2/uk unknown
- 1995-08-30 YU YU57895A patent/YU49349B/sh unknown
- 1995-08-30 SI SI9530640T patent/SI0699677T1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US6288057B1 (en) | 2001-09-11 |
YU49349B (sh) | 2005-07-19 |
PE28196A1 (es) | 1996-07-04 |
KR960007596A (ko) | 1996-03-22 |
CO4410198A1 (es) | 1997-01-09 |
YU57895A (sh) | 1998-07-10 |
MY118394A (en) | 2004-10-30 |
KR960007597A (ko) | 1996-03-22 |
ZA957279B (en) | 1997-02-28 |
US5665878A (en) | 1997-09-09 |
SI0699678T1 (en) | 2004-06-30 |
YU57795A (sh) | 1998-07-10 |
HU0003319D0 (xx) | 1995-08-30 |
CO4410199A1 (es) | 1997-01-09 |
HU223846B1 (hu) | 2005-02-28 |
NZ272896A (en) | 1997-03-24 |
TW390881B (en) | 2000-05-21 |
YU49288B (sh) | 2005-03-15 |
ZA957278B (en) | 1997-02-28 |
SI0699677T1 (en) | 2003-06-30 |
US6329364B1 (en) | 2001-12-11 |
KR100386934B1 (ko) | 2003-10-04 |
UA44698C2 (uk) | 2002-03-15 |
CO4410197A1 (es) | 1997-01-09 |
KR100386933B1 (ko) | 2003-09-19 |
PE32996A1 (es) | 1996-08-10 |
RU2142465C1 (ru) | 1999-12-10 |
UA45309C2 (uk) | 2002-04-15 |
YU49289B (sh) | 2005-03-15 |
TW372965B (en) | 1999-11-01 |
TW393485B (en) | 2000-06-11 |
UA41354C2 (uk) | 2001-09-17 |
PE32896A1 (es) | 1996-08-07 |
YU57695A (sh) | 1998-07-10 |
MY117754A (en) | 2004-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1023125A1 (en) | Crystalline form of 4-Ä5-methyl-3-phenylisoxazol-4-ylÜbenzenesulfonamide | |
GB2319250B (en) | Derivatives of 6,8-Difluoro-7-Hydroxycoumarin | |
DE69529478D1 (en) | Sdh/sonet-interface | |
HUP0100779A3 (en) | Novel derivatives of 3,3-diphenylpropylamines | |
PL337442A1 (en) | Expression adjustment of quinolane phosphoribozyltransferase | |
PL338563A1 (en) | Substituted derivatives of 1,2,3,4-tetrahydronaphtalene | |
GB9518552D0 (en) | New heterocyclic compounds | |
PL327998A1 (en) | Novel derivatives of 19-nor-pregnene | |
ZA969753B (en) | Crystalline hydrochloride of (r)-(-)-2-än-4-(1,1-dioxido-3-oxo-2,3-dihydrobenzhisothiazol-2-yl)-aminomethylü-chroman | |
PL329121A1 (en) | Substituted derivatives of 1,2,3,4-tetrahydronaphtalene | |
PL324992A1 (en) | Novel derivatives of 2,3-dioxotetrahydoquinoxaline | |
PL322722A1 (en) | Novel heterocyclic compounds | |
HUP9600272A3 (en) | 10-amino-aliphatic-dibenzo-[b,f]oxepine derivatives of antineurodegenerative activity | |
PL320190A1 (en) | Novel, physically stable form of fuoroquinolone | |
HRP970186B1 (en) | Novel 2,3-benzodiazepine derivatives | |
ZA957280B (en) | Crystalline form of dihydro-2,3-benzodiazepine derivative | |
PL310486A1 (en) | Novel compounds, derivatives of genistein | |
PL292091A1 (en) | Method of obtaining novel derivative of 5h-2,3-benzodiazepine | |
PL333079A1 (en) | Piparazinic derivatives as antagonists of neurokinin | |
IL136500A0 (en) | 1,4-diazacycloheptane derivatives | |
GB2302295B (en) | Reamer | |
PL337612A1 (en) | Crystalline form of roxyfiban | |
PL325637A1 (en) | Novel heterocyclic compounds | |
PL324400A1 (en) | Derivatives of 1,3-oxazin-4-one as herbicides | |
PL330141A1 (en) | Novel derivatives of 10,11-dihydro-10-oxo-5h-dibezyl(b,f)-azepin-5-carboxagmide |